PGNY Progyny, Inc. Stock Quote

PGNY [NASD]

Healthcare | Health Information Services | USA

Index	-	P/E	97.51	EPS (ttm)	0.57	Insider Own	9.20%	Shs Outstand	87.40M	Perf Week	2.86%
Market Cap	4.95B	Forward P/E	99.95	EPS next Y	0.56	Insider Trans	-42.56%	Shs Float	73.88M	Perf Month	-7.21%
Income	57.60M	PEG	1.58	EPS next Q	0.08	Inst Own	80.50%	Short Float	5.42%	Perf Quarter	0.97%
Sales	386.00M	P/S	12.82	EPS this Y	549.80%	Inst Trans	-6.13%	Short Ratio	3.90	Perf Half Y	16.14%
Book/sh	2.11	P/B	26.57	EPS next Y	43.85%	ROA	24.80%	Target Price	66.33	Perf Year	110.59%
Cash/sh	1.21	P/C	46.28	EPS next 5Y	61.65%	ROE	38.50%	52W Range	23.56 - 66.61	Perf YTD	32.27%
Dividend	-	P/FCF	207.01	EPS past 5Y	-	ROI	27.60%	52W High	-15.82%	Beta	-
Dividend %	-	Quick Ratio	2.30	Sales past 5Y	-	Gross Margin	21.30%	52W Low	137.99%	ATR	2.18
Employees	210	Current Ratio	2.30	Sales Q/Q	50.70%	Oper. Margin	4.20%	RSI (14)	46.07	Volatility	3.35% 4.13%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	316.10%	Profit Margin	14.90%	Rel Volume	0.55	Prev Close	56.07
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 05 AMC	Payout	0.00%	Avg Volume	1.03M	Price	56.07
Recom	1.60	SMA20	-1.11%	SMA50	-6.39%	SMA200	18.84%	Volume	0	Change	0.00%

Jun-02-21

Downgrade

Guggenheim

Buy → Neutral

Apr-29-21

Resumed

JP Morgan

Overweight

$65

Mar-10-21

Upgrade

BofA Securities

Neutral → Buy

$53

Jul-01-20

Initiated

SVB Leerink

Outperform

$35

Jun-02-20

Initiated

Guggenheim

Buy

$30

Nov-19-19

Initiated

SVB Leerink

Outperform

$28

Nov-19-19

Initiated

Piper Jaffray

Overweight

$33

Nov-19-19

Initiated

JP Morgan

Overweight

$26

Nov-19-19

Initiated

Goldman

Buy

$33

Nov-19-19

Initiated

Citigroup

Buy

$30

Jul-29-21 03:05PM	Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth Zacks
06:31AM	Are Institutions Heavily Invested In Progyny, Inc.'s (NASDAQ:PGNY) Shares? Simply Wall St.
Jul-22-21 03:30PM	Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report GlobeNewswire
12:00PM	Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade Zacks
Jul-20-21 06:45PM	3 Small-Cap Healthcare Stocks Worth a Look Motley Fool
Jul-13-21 02:05PM	Hedge Funds Are Crazy About Progyny, Inc. (PGNY) Insider Monkey
06:02AM	Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy? Zacks
Jul-07-21 03:37PM	IBD 50 Stock To Watch Progyny Has Rallied 365%; Will It Rebound Or Build A Base? Investor's Business Daily
Jun-29-21 08:10AM	Dow Jones Futures: Covid Fears Shake Up Market Rally; Facebook Tops $1 Trillion; Tesla Rival Nio Flashes Buy Signal Investor's Business Daily
Jun-23-21 12:00PM	Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy Zacks
Jun-19-21 06:51PM	These Are The 5 Best Stocks To Buy And Watch Now Investor's Business Daily
Jun-16-21 02:27PM	Dow Jones Falls As Fed Sees Rates Rising Sooner; Apple Dips; AMC Stock Plunges, Meme Names Fall Investor's Business Daily
Jun-14-21 05:20AM	Is Progyny, Inc.'s (NASDAQ:PGNY) Latest Stock Performance A Reflection Of Its Financial Health? Simply Wall St.
Jun-10-21 08:43AM	Progyny's (PGNY) Shares March Higher, Can It Continue? Zacks
Jun-04-21 11:00AM	Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference GlobeNewswire
Jun-02-21 12:20PM	Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy? Zacks
Jun-01-21 07:33AM	Is It Too Late to Buy Progyny? TheStreet.com
May-26-21 09:00AM	Largest Research Study on Decision Making of Single or Coupled Intended Fathers Selected for Presentation at 2021 ACOG Annual Clinical and Scientific Meeting and 69th Annual Pacific Coast Reproductive Society Meeting GlobeNewswire
08:50AM	Here's What Could Help Progyny (PGNY) Maintain Its Recent Price Strength Zacks
May-25-21 10:59AM	Is Progyny (PGNY) A Smart Long-Term Buy? Insider Monkey
May-21-21 07:00AM	One Of The Best Mutual Funds Focuses On Rising Midcap Stars Investor's Business Daily
May-19-21 11:04AM	Welltok Welcomes Maven and Progyny to its Connect Ecosystem Family PR Newswire
May-17-21 11:48AM	Table Trac Announces First Quarter 2021 Results PR Newswire
May-07-21 01:00PM	Progyny, Inc. to Present at the BofA Securities 2021 Health Care Conference GlobeNewswire
08:18AM	Dow Jones Futures Rise As Market Rally Awaits Jobs Report; Roku Leads Earnings Movers As Fed Warns Asset Prices 'Vulnerable' Investor's Business Daily
May-06-21 08:45PM	Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates Zacks
04:05PM	Progyny, Inc. Announces First Quarter 2021 Results GlobeNewswire
02:45PM	Progyny Inc to Host Earnings Call ACCESSWIRE
Apr-26-21 01:17AM	Is PGNY Stock A Buy or Sell? Insider Monkey +5.09%
Apr-22-21 02:05PM	Progyny, Inc. Announces Details for Its First Quarter 2021 Results Report GlobeNewswire
Apr-16-21 11:18AM	Benefits Manager Progyny Grows Even As Covid Upends Fertility Treatments Investor's Business Daily Video +5.27%
Apr-15-21 06:03PM	PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600 PR Newswire
Apr-13-21 04:02PM	Roblox Breaks Out On 110% Sales Growth, 193% Q1 EPS Estimate Investor's Business Daily
03:14PM	IBD 50 Stocks To Watch: Fertility Stock Progyny Delivers This Bullish Move, Eyes Buy Point Investor's Business Daily
05:26AM	Introducing Progyny (NASDAQ:PGNY), The Stock That Zoomed 150% In The Last Year Simply Wall St.
Apr-12-21 05:14PM	Progyny Sees Relative Strength Rating Jump To Desired 81 Investor's Business Daily
Mar-16-21 12:23PM	Alger Weatherbie Specialized Growth: Earnings Results for Progyny, Ahead of Expectations Insider Monkey
Mar-08-21 04:33AM	Does Progyny (NASDAQ:PGNY) Have The Makings Of A Multi-Bagger? Simply Wall St.
Feb-24-21 05:07PM	Dow Jones Futures: Dow Hits High As Tesla Rebounds, GameStop Skyrockets; Nvidia, Teladoc Leads Five Earnings Movers Investor's Business Daily
05:04PM	Progyny Beats As Fertility Clients Jump Amid Pandemic But Outlook Weak Investor's Business Daily
04:05PM	Progyny, Inc. Announces Fourth Quarter and Full Year 2020 Results GlobeNewswire
03:15PM	Progyny Inc to Host Earnings Call ACCESSWIRE
Feb-23-21 04:55PM	Progyny, IBD Stock Of The Day, Eyes Buy Point Ahead Of Earnings While Pandemic Freezes Fertility Investor's Business Daily
Feb-22-21 12:30PM	2 High-Growth Stocks in the Market Today Motley Fool
11:00AM	Progyny, Inc. to Participate at the 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-15-21 06:22AM	3 Healthcare Stocks I'd Buy Right Now Motley Fool
Feb-10-21 12:00PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report GlobeNewswire
Jan-29-21 03:46AM	Is Progyny, Inc. (NASDAQ:PGNY) Worth US$46.5 Based On Its Intrinsic Value? Simply Wall St.
Jan-05-21 09:00AM	Progyny, Inc. to Present at the 39th Annual JP Morgan Healthcare Conference GlobeNewswire
Dec-24-20 02:39AM	Should We Be Cautious About Progyny, Inc.'s (NASDAQ:PGNY) ROE Of 2.5%? Simply Wall St.
Dec-18-20 10:11AM	Is PGNY A Good Stock To Buy Now? Insider Monkey
Dec-11-20 12:10PM	Progyny CEO on the future of fertility treatments amid COVID-19 Yahoo Finance Video +7.23%
Nov-18-20 08:00AM	Progyny Strengthens Board of Directors with Appointments of Healthcare and Technology Leaders GlobeNewswire
Nov-16-20 12:00PM	Progyny, Inc. Announces Participation at the Piper Sandler Healthcare Conference GlobeNewswire
Nov-09-20 06:54AM	Results: Progyny, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Simply Wall St. +5.78%
Nov-05-20 07:40PM	Progyny (PGNY) Q3 Earnings Meet Estimates Zacks
04:32PM	Progyny: Q3 Earnings Insights Benzinga
04:05PM	Progyny, Inc. Announces Third Quarter 2020 Results GlobeNewswire
02:45PM	Progyny Inc to Host Earnings Call ACCESSWIRE
Oct-29-20 12:35PM	Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-23-20 12:01PM	Did You Miss Progyny's (NASDAQ:PGNY) 72% Share Price Gain? Simply Wall St.
Oct-22-20 12:05PM	Progyny, Inc. Announces Details for Its Third Quarter Results Report GlobeNewswire
Oct-19-20 09:00AM	Progyny and RMA of New York Partner on Original Research Selected for Presentation at the 76th Annual ASRM Scientific Congress and Expo GlobeNewswire
Oct-13-20 02:39PM	Hedge Funds Keep Buying Progyny, Inc. (PGNY) Insider Monkey
Oct-12-20 12:43PM	I'm Looking for Stocks That Are Setup to Breakout, and Progyny Fits That Mold TheStreet.com
Sep-18-20 05:43PM	Progyny Inc. (PGNY) Has 100% Upside Potential Insider Monkey
Sep-10-20 12:00PM	Progyny, Inc. Announces Participation at the BofA Global Healthcare Conference GlobeNewswire -6.81%
05:28AM	This Company Is Winning in the Fast-Growing Fertility Benefits Industry Motley Fool
Sep-09-20 08:00AM	Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer GlobeNewswire
Aug-19-20 11:30AM	Estimating The Intrinsic Value Of Progyny, Inc. (NASDAQ:PGNY) Simply Wall St. +11.32%
Aug-05-20 04:05PM	Progyny, Inc. Announces Second Quarter 2020 Results GlobeNewswire
Jul-31-20 11:27AM	Why Progyny (PGNY) Stock is a Compelling Investment Case Insider Monkey
Jul-22-20 12:00PM	Progyny, Inc. Announces Details for Its Second Quarter Results Report GlobeNewswire
Jul-08-20 03:42PM	Hedge Funds Have Never Been This Bullish On Progyny, Inc. (PGNY) Insider Monkey
Jun-04-20 11:58AM	Progyny, Inc. Announces Participation at the Goldman Sachs Healthcare Conference GlobeNewswire
May-29-20 01:38PM	Top Small Cap Stocks for June 2020 Investopedia
May-15-20 04:08PM	Stock Market Rally Tested: Tesla Fremont Reopens, Recent IPOs Datadog, OneMedical Soar On Earnings Investor's Business Daily
10:25AM	Analyst Forecasts For Progyny, Inc. (NASDAQ:PGNY) Are Surging Higher Simply Wall St.
May-13-20 12:28PM	Why Progyny Stock Popped 27% Motley Fool +27.53%
03:01AM	Progyny, Inc. (PGNY) Q1 2020 Earnings Call Transcript Motley Fool
May-12-20 04:26PM	Progyny Earnings Top, Even As Fertility Services 'Meaningfully Disrupted' By Virus Investor's Business Daily
04:05PM	Progyny, Inc. Announces First Quarter 2020 Results GlobeNewswire
May-05-20 02:00PM	Progyny, Inc. to Present at the BofA Securities 2020 Health Care Conference GlobeNewswire +5.17%
Apr-21-20 08:00AM	Progyny to Ring the Nasdaq Stock Market Opening Bell in Recognition of National Infertility Awareness Week® GlobeNewswire
Apr-20-20 12:00PM	Progyny, Inc. Announces Details for Its First Quarter Results Report GlobeNewswire
Apr-07-20 05:16PM	Hedge Funds Are Betting On Progyny, Inc. (PGNY) Insider Monkey
Mar-18-20 07:00AM	Progyny, Inc. Provides Update on Impact of COVID-19 GlobeNewswire -12.36%
Mar-05-20 04:33PM	Progyny Forecasts Better-Than-Expected Sales, Helped By Client Additions Investor's Business Daily
04:06PM	Progyny, Inc. Announces Fourth Quarter and Full Year 2019 Results GlobeNewswire
02:45PM	Progyny Inc to Host Earnings Call ACCESSWIRE
Mar-03-20 09:56AM	Chart Reading For Beginners: What's In A Stock Chart? Why Use Charts? Investor's Business Daily
Feb-20-20 04:00PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report GlobeNewswire
Feb-17-20 03:12PM	Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out Investor's Business Daily
Feb-12-20 04:10PM	Progyny, IBD Stock Of The Day, Flashes Buy Signal Again But Here's The Catch Investor's Business Daily +10.72%
Jan-18-20 08:00AM	XP, Progyny Lead 5 IPO Stocks Near Buy Points Investor's Business Daily
Jan-13-20 04:16PM	Progyny, IBD Stock Of The Day, Nears New Buy Point As Profitable IPO Sees Fertile Ground For Growth Investor's Business Daily +8.71%
Jan-06-20 09:00AM	Progyny, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.95%
Dec-09-19 07:29AM	These 5 New IPO Stocks Are Near Buy Points Investor's Business Daily -8.79%
Dec-05-19 08:02AM	Dow Jones Futures: Stock Market Gets Bullish Wake-Up Call; RH, Slack, Hot IPO Are Earnings Movers Investor's Business Daily +5.77%
Dec-04-19 04:49PM	Hot IPO Progyny Beats Earnings Views In First Report; Stock Jumps Toward Buy Point Investor's Business Daily

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bealer Jennifer	EVP, General Counsel	Jul 23	Option Exercise	3.95	4,070	16,076	92,718	Jul 27 06:09 PM
Payson Norman	Director	Jul 23	Sale	56.16	8,330	467,846	855,546	Jul 26 06:48 PM
Bealer Jennifer	EVP, General Counsel	Jul 23	Sale	56.40	1,930	108,846	88,648	Jul 27 06:09 PM
Payson Norman	Director	Jul 22	Sale	56.20	8,570	481,668	863,876	Jul 26 06:48 PM
TPG Group Holdings (SBS) Advis	10% Owner	Jul 06	Sale	60.10	897,778	53,956,458	10,000,000	Jul 08 04:44 PM
TPG Group Holdings (SBS) Advis	10% Owner	Jul 02	Sale	60.14	33,803	2,032,828	10,897,778	Jul 06 04:35 PM
TPG Group Holdings (SBS) Advis	10% Owner	Jul 01	Sale	60.42	168,929	10,206,640	10,931,581	Jul 06 04:35 PM
Schlanger David J	Chief Executive Officer	Jun 25	Sale	59.45	114,015	6,777,699	0	Jun 28 06:09 PM
Schlanger David J	Chief Executive Officer	Jun 24	Sale	59.46	105,987	6,301,987	114,015	Jun 28 06:09 PM
Bealer Jennifer	EVP, General Counsel	Jun 23	Option Exercise	2.85	6,362	18,162	92,718	Jun 25 04:36 PM
Anevski Peter	President and COO	Jun 23	Option Exercise	0.93	73,538	68,344	488,617	Jun 25 04:34 PM
Bealer Jennifer	EVP, General Counsel	Jun 23	Sale	60.23	1,940	116,844	88,648	Jun 25 04:36 PM
TPG Group Holdings (SBS) Advis	10% Owner	Jun 22	Sale	59.23	3,000,000	177,682,500	11,447,471	Jun 23 07:04 PM
Livingston Mark S.	Chief Financial Officer	Jun 21	Option Exercise	5.18	44,064	228,110	61,185	Jun 23 06:40 PM
Livingston Mark S.	Chief Financial Officer	Jun 21	Sale	62.40	23,221	1,448,901	15,655	Jun 23 06:40 PM
TPG Group Holdings (SBS) Advis	10% Owner	Jun 21	Sale	64.19	277,647	17,823,494	14,447,471	Jun 23 07:04 PM
Anevski Peter	President and COO	Jun 04	Sale	62.56	21,000	1,313,852	0	Jun 07 09:57 PM
Schlanger David J	Chief Executive Officer	Jun 03	Option Exercise	0.91	50,000	45,500	50,000	Jun 07 09:58 PM
Schlanger David J	Chief Executive Officer	Jun 03	Sale	62.50	50,000	3,124,908	0	Jun 07 09:58 PM
Anevski Peter	President and COO	Jun 03	Sale	62.49	21,000	1,312,290	21,000	Jun 07 09:57 PM
Schlanger David J	Chief Executive Officer	Jun 02	Option Exercise	0.91	50,000	45,500	50,000	Jun 03 09:23 PM
Schlanger David J	Chief Executive Officer	Jun 02	Sale	63.70	50,000	3,184,984	0	Jun 03 09:23 PM
Anevski Peter	President and COO	Jun 02	Sale	65.28	42,000	2,741,760	42,000	Jun 07 09:57 PM
Anevski Peter	President and COO	Jun 02	Sale	63.36	18,700	1,184,866	44,300	Jun 03 09:20 PM
Schlanger David J	Chief Executive Officer	Jun 01	Option Exercise	0.91	50,000	45,500	50,000	Jun 03 09:23 PM
Schlanger David J	Chief Executive Officer	Jun 01	Sale	63.98	50,000	3,198,834	0	Jun 03 09:23 PM
Anevski Peter	President and COO	Jun 01	Sale	63.99	21,000	1,343,858	63,000	Jun 03 09:20 PM
Bealer Jennifer	EVP, General Counsel	May 11	Option Exercise	0.91	2,291	2,085	86,356	May 12 07:48 PM
Anevski Peter	President and COO	May 06	Sale	51.60	21,000	1,083,520	0	May 07 04:46 PM
Schlanger David J	Chief Executive Officer	May 05	Option Exercise	0.91	50,000	45,500	50,000	May 07 07:36 PM
Anevski Peter	President and COO	May 05	Sale	53.21	21,000	1,117,375	21,000	May 07 04:46 PM
Schlanger David J	Chief Executive Officer	May 05	Sale	53.21	50,000	2,660,365	0	May 07 07:36 PM
Schlanger David J	Chief Executive Officer	May 04	Option Exercise	0.91	50,000	45,500	50,000	May 05 05:58 PM
Anevski Peter	President and COO	May 04	Sale	54.20	21,000	1,138,213	42,000	May 05 04:46 PM
Schlanger David J	Chief Executive Officer	May 04	Sale	54.19	50,000	2,709,528	0	May 05 05:58 PM
Schlanger David J	Chief Executive Officer	May 03	Option Exercise	0.91	50,000	45,500	50,000	May 05 05:58 PM
Schlanger David J	Chief Executive Officer	May 03	Sale	55.79	50,000	2,789,631	0	May 05 05:58 PM
Anevski Peter	President and COO	May 03	Sale	56.18	21,000	1,179,841	63,000	May 05 04:46 PM
Bealer Jennifer	EVP, General Counsel	Apr 23	Option Exercise	3.95	4,069	16,073	88,134	Apr 27 04:58 PM
Bealer Jennifer	EVP, General Counsel	Apr 23	Sale	51.47	2,401	123,570	84,065	Apr 27 04:58 PM
Payson Norman	Director	Apr 22	Sale	51.18	5,000	255,912	350,000	Apr 23 04:59 PM
Payson Norman	Director	Apr 21	Sale	49.78	5,000	248,920	355,000	Apr 23 04:59 PM
Greenbaum Lisa	EVP, Chief Client Officer	Apr 15	Option Exercise	3.95	5,000	19,750	16,746	Apr 19 05:38 PM
Payson Norman	Director	Apr 15	Sale	50.32	5,000	251,600	360,000	Apr 16 07:54 PM
KLEINER PERKINS CAUFIELD & BYE	10% Owner	Apr 15	Sale	50.32	18,127	912,151	8,805,015	Apr 19 07:24 PM
SEIDENBERG BETH C	Director	Apr 15	Sale	50.32	18,127	912,151	8,805,015	Apr 19 09:45 PM
Greenbaum Lisa	EVP, Chief Client Officer	Apr 15	Sale	50.46	2,353	118,737	11,746	Apr 19 05:38 PM
Payson Norman	Director	Apr 14	Sale	49.57	5,000	247,833	365,000	Apr 16 07:54 PM
Schlanger David J	Chief Executive Officer	Apr 08	Option Exercise	0.91	36,676	33,375	36,676	Apr 09 07:18 PM
Payson Norman	Director	Apr 08	Sale	45.47	5,000	227,350	370,000	Apr 09 07:12 PM
Anevski Peter	President and COO	Apr 08	Sale	45.57	33,382	1,521,218	0	Apr 09 07:14 PM
Schlanger David J	Chief Executive Officer	Apr 08	Sale	45.58	36,676	1,671,692	0	Apr 09 07:18 PM
Schlanger David J	Chief Executive Officer	Apr 07	Option Exercise	0.91	300	273	300	Apr 09 07:18 PM
Payson Norman	Director	Apr 07	Sale	44.93	5,000	224,655	375,000	Apr 09 07:12 PM
Anevski Peter	President and COO	Apr 07	Sale	45.74	200	9,148	33,382	Apr 09 07:14 PM
Schlanger David J	Chief Executive Officer	Apr 07	Sale	45.78	300	13,734	0	Apr 09 07:18 PM
Schlanger David J	Chief Executive Officer	Apr 06	Option Exercise	0.91	77,590	70,607	77,590	Apr 07 04:27 PM
Anevski Peter	President and COO	Apr 06	Sale	46.08	22,785	1,049,933	33,582	Apr 07 04:14 PM
Schlanger David J	Chief Executive Officer	Apr 06	Sale	46.10	77,590	3,576,899	0	Apr 07 04:27 PM
Schlanger David J	Chief Executive Officer	Apr 05	Option Exercise	0.91	34,430	31,331	34,430	Apr 07 04:27 PM
Schlanger David J	Chief Executive Officer	Apr 05	Sale	46.10	34,430	1,587,223	0	Apr 07 04:27 PM
Anevski Peter	President and COO	Apr 05	Sale	46.08	26,833	1,236,465	56,367	Apr 07 04:14 PM
Schlanger David J	Chief Executive Officer	Apr 01	Option Exercise	0.91	1,004	914	1,004	Apr 05 04:12 PM
Schlanger David J	Chief Executive Officer	Apr 01	Sale	46.19	1,004	46,375	0	Apr 05 04:12 PM
Anevski Peter	President and COO	Apr 01	Sale	46.19	800	36,952	83,200	Apr 05 04:08 PM
Payson Norman	Director	Mar 31	Sale	44.11	5,000	220,525	380,000	Mar 31 08:29 PM
Bealer Jennifer	EVP, General Counsel	Mar 30	Option Exercise	0.91	2,292	2,086	84,065	Mar 31 05:33 PM
Payson Norman	Director	Mar 30	Sale	43.35	5,000	216,741	385,000	Mar 31 08:29 PM
Payson Norman	Director	Mar 25	Sale	44.93	5,000	224,668	390,000	Mar 26 05:42 PM
Payson Norman	Director	Mar 24	Sale	48.48	5,000	242,394	395,000	Mar 26 05:42 PM
Bealer Jennifer	EVP, General Counsel	Mar 23	Option Exercise	3.95	4,071	16,080	85,844	Mar 25 06:10 PM
Bealer Jennifer	EVP, General Counsel	Mar 23	Sale	48.54	2,468	119,801	81,773	Mar 25 06:10 PM
Payson Norman	Director	Mar 18	Sale	47.38	5,000	236,894	400,000	Mar 19 06:39 AM
Payson Norman	Director	Mar 17	Sale	48.14	5,000	240,675	405,000	Mar 19 06:39 AM
Greenbaum Lisa	EVP, Chief Client Officer	Mar 15	Option Exercise	3.95	5,000	19,750	16,746	Mar 17 09:13 PM
Greenbaum Lisa	EVP, Chief Client Officer	Mar 15	Sale	48.69	3,032	147,631	11,746	Mar 17 09:13 PM
Schlanger David J	Chief Executive Officer	Mar 12	Option Exercise	0.91	55,430	50,441	55,430	Mar 12 08:01 PM
Schlanger David J	Chief Executive Officer	Mar 12	Sale	47.57	55,430	2,636,805	0	Mar 12 08:01 PM
Schlanger David J	Chief Executive Officer	Mar 11	Option Exercise	0.91	81,567	74,226	81,567	Mar 12 08:01 PM
Payson Norman	Director	Mar 11	Sale	47.24	5,000	236,200	410,000	Mar 12 05:29 PM
Anevski Peter	President and COO	Mar 11	Sale	47.30	75,001	3,547,547	84,000	Mar 12 05:49 PM
Schlanger David J	Chief Executive Officer	Mar 11	Sale	47.31	81,567	3,858,935	0	Mar 12 08:01 PM
Schlanger David J	Chief Executive Officer	Mar 10	Option Exercise	0.91	13,003	11,833	13,003	Mar 12 08:01 PM
Anevski Peter	President and COO	Mar 10	Sale	47.43	8,999	426,823	159,001	Mar 12 05:49 PM
Payson Norman	Director	Mar 10	Sale	46.34	5,000	231,680	415,000	Mar 12 05:29 PM
Schlanger David J	Chief Executive Officer	Mar 10	Sale	47.50	13,003	617,642	0	Mar 12 08:01 PM
Payson Norman	Director	Mar 04	Sale	41.37	5,000	206,853	420,000	Mar 05 06:20 PM
Payson Norman	Director	Mar 03	Sale	42.91	5,000	214,574	425,000	Mar 05 06:20 PM
Bealer Jennifer	EVP, General Counsel	Mar 01	Option Exercise	0.91	2,292	2,086	74,773	Mar 03 09:08 PM
Bealer Jennifer	EVP, General Counsel	Feb 23	Option Exercise	3.95	4,069	16,073	76,550	Feb 25 06:06 PM
Bealer Jennifer	EVP, General Counsel	Feb 23	Sale	49.76	2,472	123,007	72,481	Feb 25 06:06 PM
Payson Norman	Director	Feb 18	Sale	48.93	5,000	244,634	440,000	Feb 19 04:22 PM
Payson Norman	Director	Feb 17	Sale	49.24	5,000	246,186	445,000	Feb 19 04:22 PM
Greenbaum Lisa	EVP, Chief Client Officer	Feb 16	Option Exercise	3.95	5,000	19,750	10,044	Feb 18 09:53 PM
Bealer Jennifer	EVP, General Counsel	Feb 16	Option Exercise	0.91	6,875	6,256	72,481	Feb 18 08:58 PM
Greenbaum Lisa	EVP, Chief Client Officer	Feb 16	Sale	51.00	3,046	155,346	5,044	Feb 18 09:53 PM
Payson Norman	Director	Feb 11	Sale	50.06	5,000	250,296	450,000	Feb 12 04:34 PM
Payson Norman	Director	Feb 10	Sale	49.67	5,000	248,354	455,000	Feb 12 04:34 PM
Anevski Peter	President and COO	Feb 04	Sale	49.04	21,000	1,029,793	168,000	Feb 05 05:12 PM
Payson Norman	Director	Feb 04	Sale	49.06	5,000	245,280	460,000	Feb 05 05:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience